These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 24547721)

  • 1. Proton pump inhibitor-induced subacute cutaneous lupus erythematosus.
    Sandholdt LH; Laurinaviciene R; Bygum A
    Br J Dermatol; 2014 Feb; 170(2):342-51. PubMed ID: 24547721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
    Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N
    Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors-related subacute cutaneous lupus erythematosus: Clinical characteristics, management, and outcome.
    Deng Z; Guo A; Wu C; Wang C
    J Cosmet Dermatol; 2022 Dec; 21(12):7202-7208. PubMed ID: 36214602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.
    Toms-Whittle LM; John LH; Buckley DA
    Clin Exp Dermatol; 2011 Apr; 36(3):281-3. PubMed ID: 20738320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced cutaneous lupus erythematosus: 88 new cases.
    Laurinaviciene R; Sandholdt LH; Bygum A
    Eur J Dermatol; 2017 Feb; 27(1):28-33. PubMed ID: 27799135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor induced subacute cutaneous lupus erythematosus: Clinical characteristics and outcomes.
    Poh YJ; Alrashid A; Sangle SR; Higgins E; Benton E; McGibbon D; D'Cruz DP
    Lupus; 2022 Aug; 31(9):1078-1083. PubMed ID: 35635045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rowell's Syndrome Triggered by Omeprazole.
    Pozharashka J; Dourmishev L; Balabanova M; Vassileva S; Miteva L
    Acta Dermatovenerol Croat; 2019 Jun; 27(2):124-126. PubMed ID: 31351509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Pump Inhibitor Induced Subacute Cutaneous Lupus Erythematosus: A Case Series of 7 Patients and Brief Review of Literature.
    Kaur S; Singla P; Kaur S; Kansal A; Bansal A; Singh A
    Indian Dermatol Online J; 2022; 13(1):64-72. PubMed ID: 35198470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of drug-induced subacute cutaneous lupus erythematosus.
    Lowe GC; Henderson CL; Grau RH; Hansen CB; Sontheimer RD
    Br J Dermatol; 2011 Mar; 164(3):465-72. PubMed ID: 21039412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute cutaneous lupus erythematosus induced by nifedipine.
    Gubinelli E; Cocuroccia B; Girolomoni G
    J Cutan Med Surg; 2003; 7(3):243-6. PubMed ID: 12574905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
    Marzano AV; Lazzari R; Polloni I; Crosti C; Fabbri P; Cugno M
    Br J Dermatol; 2011 Aug; 165(2):335-41. PubMed ID: 21564069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Esomeprazol-induced cutaneous lupus erythematosus].
    Gliem N; Broekaert SMC; Seitz CS; Schön MP; Ellenrieder V
    Z Gastroenterol; 2017 Sep; 55(9):861-865. PubMed ID: 29186640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents.
    Dalle Vedove C; Simon JC; Girolomoni G
    J Dtsch Dermatol Ges; 2012 Dec; 10(12):889-97. PubMed ID: 22937775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [When drugs induce cutaneous lupus erythematosus].
    Skovmøller KB; Bygum A
    Ugeskr Laeger; 2018 Oct; 180(41):. PubMed ID: 30327081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Bonsmann G; Schiller M; Luger TA; Ständer S
    J Am Acad Dermatol; 2001 Jun; 44(6):925-31. PubMed ID: 11369902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature.
    Lorentz K; Booken N; Goerdt S; Goebeler M
    J Dtsch Dermatol Ges; 2008 Oct; 6(10):823-7, 823-8. PubMed ID: 18564209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute cutaneous lupus erythematosus.
    David-Bajar KM
    J Invest Dermatol; 1993 Jan; 100(1):2S-8S. PubMed ID: 8423385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors and subacute cutaneous lupus erythematosus: an under-recognized phenomenon?
    Cookson H; Walsh S
    Br J Dermatol; 2014 Feb; 170(2):235. PubMed ID: 24547716
    [No Abstract]   [Full Text] [Related]  

  • 19. Acebutolol-induced subacute cutaneous lupus erythematosus.
    Fenniche S; Dhaoui A; Ammar FB; Benmously R; Marrak H; Mokhtar I
    Skin Pharmacol Physiol; 2005; 18(5):230-3. PubMed ID: 16015021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus: clinical expression and anti-Ro/SS--a response in patients with and without lesions of subacute cutaneous lupus erythematosus.
    López-Longo FJ; Monteagudo I; González CM; Grau R; Carreño L
    Lupus; 1997; 6(1):32-9. PubMed ID: 9116716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.